Saadat Payam, Mohseni-Ahangar Reza
Department of Neurology, Babol University of Medical Sciences, Babol, Iran.
Babol University of Medical Sciences, Babol, Iran.
Caspian J Intern Med. 2017 Winter;8(1):56-58.
Cerebral venous sinus thrombosis is a rare and potentially life-threatening neurologic manifestation of antiphospholipid syndrome. Oral contraceptive pills (OCP) may increase the risk of vascular events, even in people without family history of venous thrombosis.
A 31-year-old woman with four weeks of constant headache and history of taking OCP for one year has been selected for this study. The results of magnetic resonance imaging (MRI) of brain and venography confirmed a diagnosis of cerebral venous sinus thrombosis. The serum anticardiolipin and antiphospholipid antibodies were elevated and a definitive diagnosis of antiphospholipid syndrome was made.
The present report demonstrates the importance of screening for antiphospholipid antibodies in patients presenting with cerebral venous sinus thrombosis despite history of taking OCP.
脑静脉窦血栓形成是抗磷脂综合征一种罕见且可能危及生命的神经表现。口服避孕药(OCP)可能会增加血管事件的风险,即使在没有静脉血栓家族史的人群中也是如此。
本研究选取了一名31岁女性,该女性持续头痛四周,且有服用OCP一年的病史。脑部磁共振成像(MRI)和静脉造影结果证实诊断为脑静脉窦血栓形成。血清抗心磷脂和抗磷脂抗体升高,最终确诊为抗磷脂综合征。
本报告表明,对于出现脑静脉窦血栓形成的患者,尽管有服用OCP的病史,但筛查抗磷脂抗体仍很重要。